ASND : Ascendis Pharma A/S stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
year | Average | Low | High | Change from close on 2024-10-07 |
---|---|---|---|---|
2024 | $147.15 | $145.99 | $148.32 | 5.76% |
2025 | $147.44 | $127.88 | $158.75 | 5.97% |
2026 | $105.72 | $95.99 | $124.46 | -24.02% |
2027 | $98.14 | $89.76 | $112.17 | -29.47% |
2028 | $114.3 | $113.77 | $115.05 | -17.85% |
2029 | $122.32 | $114.8 | $126.31 | -12.09% |
2030 | $115.42 | $108.14 | $123.45 | -17.05% |
2031 | $94.19 | $82.01 | $106.33 | -32.31% |
2032 | $75.08 | $72.75 | $80.44 | -46.04% |
2033 | $75.16 | $72.08 | $79.78 | -45.99% |
2034 | $93.06 | $81.44 | $102.58 | -33.12% |
The 27 Wall Street analysts offering Ascendis Pharma A/S stock forecast in the last 6 months have average price target of
$187.33 with a high forecast of $289.0 and a low forecast of $116.0.
The average Ascendis Pharma A/S stock forecast represents a 34.63%
increase from the last price of $139.139999389648.
For Ascendis Pharma A/S stock forecast for 2024, 2 predictions are offered for each month of 2024 with average Ascendis Pharma A/S stock
forecast of $147.15, a high forecast of $148.32, and a low forecast of $145.99.
The average Ascendis Pharma A/S stock forecast 2024 represents a 5.76%
increase from the last price of $139.139999389648.
For Ascendis Pharma A/S stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Ascendis Pharma A/S stock
forecast of $147.44, a high forecast of $158.75, and a low forecast of $127.88.
The average Ascendis Pharma A/S stock forecast 2025 represents a 5.97%
increase from the last price of $139.139999389648.
For Ascendis Pharma A/S stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Ascendis Pharma A/S stock
forecast of $98.14, a high forecast of $112.17, and a low forecast of $89.76.
The average Ascendis Pharma A/S stock forecast 2027 represents a -29.47%
decrease from the last price of $139.139999389648.
For Ascendis Pharma A/S stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Ascendis Pharma A/S stock
forecast of $122.32, a high forecast of $126.31, and a low forecast of $114.8.
The average Ascendis Pharma A/S stock forecast 2029 represents a -12.09%
decrease from the last price of $139.139999389648.
For Ascendis Pharma A/S stock forecast 2030, 12 predictions are offered for each month of 2030 with average Ascendis Pharma A/S stock
forecast of $115.42, a high forecast of $123.45, and a low forecast of $108.14.
The average Ascendis Pharma A/S stock forecast 2030 represents a -17.05%
decrease from the last price of $139.139999389648.
For Ascendis Pharma A/S stock forecast for 2034 (10 year), 10 predictions are offered for each month of 2034 with average Ascendis Pharma A/S stock
forecast of $93.06, a high forecast of $102.58, and a low forecast of $81.44.
The average Ascendis Pharma A/S stock forecast 2034 represents a -33.12%
decrease from the last price of $139.139999389648.
Please, see more forecasts below.
ASND : Ascendis Pharma A/S stock forecast by Wall Street Analysts
The average Ascendis Pharma A/S stock forecast from last 6 month is $187.33, and this show a 4.13% increase in average from the prior price target of the each prediction. Also, this average forecast of $187.33 represents a 4.99% increase from the past average forecast of $178.42, 6 months ago from 12 wall street analysts.
Date | Firm | previous price target | current price target | current rating |
---|---|---|---|---|
2024-09-23 | B of A Securities | $175.00 | $191 | Buy |
2024-09-17 | Goldman Sachs | $180.0000 | $200 | Buy |
2024-09-17 | Oppenheimer | $180.00 | $190 | Outperform |
2024-09-17 | Evercore ISI Group | $191.0000 | $205.0000 | Outperform |
2024-09-17 | Citigroup | $178.00 | $207.0000 | Buy |
2024-09-17 | Wells Fargo | $264.00 | $289.0000 | Overweight |
2024-09-16 | Cantor Fitzgerald | $170.00 | $170.00 | Overweight |
2024-09-09 | Cantor Fitzgerald | $170.00 | $170.0000 | Overweight |
2024-09-05 | Oppenheimer | $180 | Outperform | |
2024-09-04 | Cantor Fitzgerald | $173.00 | $170 | Overweight |
2024-09-04 | Citigroup | $193.0000 | $178.0000 | Buy |
2024-09-04 | JP Morgan | $174.00 | $165.0000 | Overweight |
2024-09-04 | TD Cowen | $175.00 | $157.0000 | Buy |
2024-09-04 | B of A Securities | $165.0000 | $175 | Buy |
2024-09-04 | Wells Fargo | $277.0000 | $264.0000 | Overweight |
2024-08-21 | JP Morgan | $170.00 | $174.0000 | Overweight |
2024-08-13 | Goldman Sachs | $170.0000 | $195 | Buy |
2024-08-13 | Jefferies | $174.0000 | $196.0000 | Buy |
2024-06-25 | TD Cowen | $156.0000 | $175.0000 | Buy |
2024-05-31 | Stifel | $200 | Buy | |
2024-05-16 | Morgan Stanley | $116.00 | $140 | Equal-Weight |
2024-05-15 | Cantor Fitzgerald | $173.0000 | Overweight | |
2024-05-03 | Cantor Fitzgerald | $173.0000 | Overweight | |
2024-05-03 | JP Morgan | $167.00 | $170.0000 | Overweight |
2024-05-03 | Wells Fargo | $260.0000 | $262.0000 | Overweight |
2024-04-22 | Morgan Stanley | $116.00 | $116 | Equal-Weight |
2024-04-18 | Cantor Fitzgerald | $173.0000 | Overweight | |
2024-04-02 | JP Morgan | $165.0000 | $167.0000 | Overweight |
2024-04-01 | Cantor Fitzgerald | $173.0000 | Overweight | |
2024-03-15 | Wells Fargo | $196.0000 | $260 | Overweight |
2024-02-08 | Wedbush | $207.0000 | $225 | Outperform |
2024-02-08 | Citigroup | $146.00 | $182 | Buy |
2024-02-06 | Cantor Fitzgerald | $152.0000 | $173.0000 | Overweight |
2023-12-20 | Jefferies | $150.0000 | Buy | |
2023-12-20 | Wedbush | $200.0000 | $202.0000 | Outperform |
2023-12-20 | Cantor Fitzgerald | $152.0000 | Overweight | |
2023-12-19 | Wells Fargo | $137.0000 | $149 | Overweight |
2023-11-09 | Morgan Stanley | $113.00 | $116 | Equal-Weight |
2023-11-08 | Wedbush | $192.0000 | Outperform |
Ascendis Pharma A/S stock forecast for upcoming days
Date | Price Target | Change |
---|---|---|
2024-10-09 | $137.41 | -1.24% |
2024-10-10 | $137.08 | -0.24% |
2024-10-11 | $137.30 | 0.16% |
2024-10-14 | $137.27 | -0.02% |
2024-10-15 | $137.23 | -0.02% |
ASND : Long term Ascendis Pharma A/S stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Nov. is $145.99 , for 2025 Oct. is $136.37 , for 2028 Oct. is $113.88 , for 2029 Oct. is $126.18 , for 2033 Oct. is $77.66 , and for 2034 Oct. is $102.58.
ASND : Ascendis Pharma A/S stock forecast for 2024
Date | Price Target | Change |
---|---|---|
2024 Nov. | $145.99 | 4.92% |
2024 Dec. | $148.32 | 1.59% |
ASND : Ascendis Pharma A/S stock forecast for 2025
Date | Price Target | Change |
---|---|---|
2025 Jan. | $149.45 | 0.77% |
2025 Feb. | $152.04 | 1.73% |
2025 Mar. | $153.94 | 1.25% |
2025 Apr. | $157.27 | 2.16% |
2025 May. | $158.75 | 0.94% |
2025 Jun. | $157.45 | -0.82% |
2025 Jul. | $154.83 | -1.67% |
2025 Aug. | $148.22 | -4.26% |
2025 Sep. | $141.59 | -4.47% |
2025 Oct. | $136.37 | -3.69% |
2025 Nov. | $131.50 | -3.57% |
2025 Dec. | $127.88 | -2.75% |
ASND : Ascendis Pharma A/S stock forecast for 2026
Date | Price Target | Change |
---|---|---|
2026 Jan. | $124.46 | -2.67% |
2026 Feb. | $118.84 | -4.52% |
2026 Mar. | $113.75 | -4.29% |
2026 Apr. | $109.69 | -3.56% |
2026 May. | $106.83 | -2.61% |
2026 Jun. | $104.22 | -2.45% |
2026 Jul. | $101.64 | -2.47% |
2026 Aug. | $99.62 | -1.99% |
2026 Sep. | $98.22 | -1.41% |
2026 Oct. | $98.02 | -0.20% |
2026 Nov. | $97.39 | -0.65% |
2026 Dec. | $95.99 | -1.43% |
ASND : Ascendis Pharma A/S stock forecast for 2027
Date | Price Target | Change |
---|---|---|
2027 Jan. | $94.93 | -1.11% |
2027 Feb. | $92.98 | -2.06% |
2027 Mar. | $90.76 | -2.38% |
2027 Apr. | $89.76 | -1.11% |
2027 May. | $90.35 | 0.66% |
2027 Jun. | $92.31 | 2.17% |
2027 Jul. | $95.19 | 3.12% |
2027 Aug. | $99.21 | 4.22% |
2027 Sep. | $103.35 | 4.17% |
2027 Oct. | $106.92 | 3.46% |
2027 Nov. | $109.75 | 2.65% |
2027 Dec. | $112.17 | 2.21% |
ASND : Ascendis Pharma A/S stock forecast for 2028
Date | Price Target | Change |
---|---|---|
2028 Jan. | $113.95 | 1.59% |
2028 Feb. | $114.81 | 0.75% |
2028 Mar. | $115.05 | 0.22% |
2028 Apr. | $114.97 | -0.07% |
2028 May. | $114.70 | -0.23% |
2028 Jun. | $114.35 | -0.30% |
2028 Jul. | $114.01 | -0.30% |
2028 Aug. | $113.80 | -0.19% |
2028 Sep. | $113.77 | -0.03% |
2028 Oct. | $113.88 | 0.10% |
2028 Nov. | $114.07 | 0.16% |
2028 Dec. | $114.27 | 0.18% |
ASND : Ascendis Pharma A/S stock forecast for 2029
Date | Price Target | Change |
---|---|---|
2029 Jan. | $114.80 | 0.46% |
2029 Feb. | $116.40 | 1.40% |
2029 Mar. | $118.15 | 1.50% |
2029 Apr. | $119.90 | 1.49% |
2029 May. | $121.69 | 1.49% |
2029 Jun. | $123.38 | 1.39% |
2029 Jul. | $124.82 | 1.17% |
2029 Aug. | $125.86 | 0.83% |
2029 Sep. | $126.31 | 0.36% |
2029 Oct. | $126.18 | -0.11% |
2029 Nov. | $125.66 | -0.41% |
2029 Dec. | $124.74 | -0.73% |
ASND : Ascendis Pharma A/S stock forecast for 2030
Date | Price Target | Change |
---|---|---|
2030 Jan. | $123.45 | -1.03% |
2030 Feb. | $121.84 | -1.30% |
2030 Mar. | $120.02 | -1.50% |
2030 Apr. | $118.26 | -1.47% |
2030 May. | $116.82 | -1.22% |
2030 Jun. | $115.64 | -1.01% |
2030 Jul. | $114.54 | -0.94% |
2030 Aug. | $113.44 | -0.97% |
2030 Sep. | $112.24 | -1.05% |
2030 Oct. | $110.97 | -1.13% |
2030 Nov. | $109.64 | -1.20% |
2030 Dec. | $108.14 | -1.37% |
ASND : Ascendis Pharma A/S stock forecast for 2031
Date | Price Target | Change |
---|---|---|
2031 Jan. | $106.33 | -1.68% |
2031 Feb. | $104.22 | -1.98% |
2031 Mar. | $101.97 | -2.15% |
2031 Apr. | $99.72 | -2.21% |
2031 May. | $97.55 | -2.17% |
2031 Jun. | $95.50 | -2.11% |
2031 Jul. | $93.39 | -2.21% |
2031 Aug. | $91.04 | -2.52% |
2031 Sep. | $88.54 | -2.74% |
2031 Oct. | $86.11 | -2.74% |
2031 Nov. | $83.91 | -2.56% |
2031 Dec. | $82.01 | -2.26% |
ASND : Ascendis Pharma A/S stock forecast for 2032
Date | Price Target | Change |
---|---|---|
2032 Jan. | $80.44 | -1.92% |
2032 Feb. | $79.10 | -1.67% |
2032 Mar. | $77.79 | -1.66% |
2032 Apr. | $76.40 | -1.78% |
2032 May. | $75.09 | -1.72% |
2032 Jun. | $74.07 | -1.35% |
2032 Jul. | $73.44 | -0.85% |
2032 Aug. | $73.12 | -0.44% |
2032 Sep. | $72.99 | -0.18% |
2032 Oct. | $72.93 | -0.08% |
2032 Nov. | $72.86 | -0.10% |
2032 Dec. | $72.75 | -0.16% |
ASND : Ascendis Pharma A/S stock forecast for 2033
Date | Price Target | Change |
---|---|---|
2033 Jan. | $72.57 | -0.24% |
2033 Feb. | $72.32 | -0.34% |
2033 Mar. | $72.08 | -0.34% |
2033 Apr. | $72.13 | 0.08% |
2033 May. | $73.04 | 1.25% |
2033 Jun. | $74.38 | 1.85% |
2033 Jul. | $75.69 | 1.75% |
2033 Aug. | $76.60 | 1.21% |
2033 Sep. | $77.09 | 0.63% |
2033 Oct. | $77.66 | 0.75% |
2033 Nov. | $78.54 | 1.13% |
2033 Dec. | $79.78 | 1.57% |
ASND : Ascendis Pharma A/S stock forecast for 2034
Date | Price Target | Change |
---|---|---|
2034 Jan. | $81.44 | 2.08% |
2034 Feb. | $83.61 | 2.66% |
2034 Mar. | $86.32 | 3.24% |
2034 Apr. | $89.44 | 3.61% |
2034 May. | $92.60 | 3.54% |
2034 Jun. | $95.49 | 3.12% |
2034 Jul. | $97.93 | 2.55% |
2034 Aug. | $99.84 | 1.95% |
2034 Sep. | $101.34 | 1.50% |
2034 Oct. | $102.58 | 1.22% |
Frequently Asked Questions about Ascendis Pharma A/S stock forecast
Is Ascendis Pharma A/S a good long term stock?
From Ascendis Pharma A/S stock forecast , Ascendis Pharma A/S (ASND) stock can be a good investment choice. According to AIPickup, the Ascendis Pharma A/S stock price forecast for 2024 Nov. is $145.990410162529 From Ascendis Pharma A/S stock forecast , Ascendis Pharma A/S (ASND) stock cannot be a good investment choice. According to AIPickup, the Ascendis Pharma A/S stock price forecast for 2025 Oct. is $136.373433989511 From Ascendis Pharma A/S stock forecast , Ascendis Pharma A/S (ASND) stock cannot be a good investment choice. According to AIPickup, the Ascendis Pharma A/S stock price forecast for 2028 Oct. is $113.878795394131 From Ascendis Pharma A/S stock forecast , Ascendis Pharma A/S (ASND) stock cannot be a good investment choice. According to AIPickup, the Ascendis Pharma A/S stock price forecast for 2029 Oct. is $126.177660297421 From Ascendis Pharma A/S stock forecast , Ascendis Pharma A/S (ASND) stock cannot be a good investment choice. According to AIPickup, the Ascendis Pharma A/S stock price forecast for 2033 Oct. is $77.6638611340478 From Ascendis Pharma A/S stock forecast , Ascendis Pharma A/S (ASND) stock cannot be a good investment choice. According to AIPickup, the Ascendis Pharma A/S stock price forecast for 2034 Oct. is $102.582329158776
Is Ascendis Pharma A/S stock overvalued?
Ascendis Pharma A/S (ASND) stock is expected to go DOWN . Therefore, AIPickup would say that Ascendis Pharma A/S (ASND) stock is overvalued.
Will Ascendis Pharma A/S stock price go up?
No. The Ascendis Pharma A/S stock price forecast for 2025 Oct. is $136.373433989511
Is Ascendis Pharma A/S stock a good buy now?
Since closing price on 2024-10-07 is $139.139999389648 and forecast for 2025 Oct. is $136.37, Ascendis Pharma A/S stock is not a good 1 year investment.
14 Days Historical Data for Ascendis Pharma A/S stock price
Date | Close | Open | Low | High |
---|---|---|---|---|
ASND stock price for 2024-09-18 | $148.88 | $146.59 | $145.77 | $150.43 |
ASND stock price for 2024-09-19 | $153.43 | $151.00 | $149.26 | $154.81 |
ASND stock price for 2024-09-20 | $151.26 | $153.75 | $150.85 | $155.53 |
ASND stock price for 2024-09-23 | $146.60 | $151.48 | $145.72 | $151.87 |
ASND stock price for 2024-09-24 | $144.89 | $145.98 | $143.98 | $147.58 |
ASND stock price for 2024-09-25 | $146.27 | $144.78 | $144.73 | $149.56 |
ASND stock price for 2024-09-26 | $147.36 | $147.64 | $144.43 | $147.64 |
ASND stock price for 2024-09-27 | $144.62 | $147.01 | $142.98 | $148.31 |
ASND stock price for 2024-09-30 | $149.31 | $143.69 | $143.12 | $149.67 |
ASND stock price for 2024-10-01 | $146.60 | $149.31 | $144.12 | $149.31 |
ASND stock price for 2024-10-02 | $146.29 | $146.47 | $144.88 | $147.96 |
ASND stock price for 2024-10-03 | $140.95 | $145.20 | $140.54 | $146.23 |
ASND stock price for 2024-10-04 | $142.67 | $141.65 | $139.56 | $142.80 |
ASND stock price for 2024-10-07 | $139.14 | $141.65 | $139.00 | $142.07 |